Stool test gaps for women, Jalen Hurts’ blood clots, a new women’s health order and training for stronger bones for today's ...
Known differences in colorectal cancer characteristics between men and women are also observed in fecal immunochemical tests.
Guardant Health's Shield blood test achieved 99% real-world adherence in two rural clinics, far exceeding typical 28-71% ...
A large screening study across 13 regions of Shandong Province, China, finds that a fecal immunochemical test threshold of 25 µg/g detects 96.4% of colorectal cancers while cutting the colonoscopy ...
Experts explain what types of stools aren't normal and how to tell if something unusual could be a sign of a more serious ...
Fecal immunochemical tests appear more sensitive to colorectal cancer and advanced precancerous lesions in men than women, ...
Modeling presented at ACG 2026 shows Guardant Health’s blood-based colorectal cancer screening averts more deaths and ...
Guardant Health, Inc. announced the company and its research collaborators presented new data showing the critical role of blood-based testing in increasing overall colorectal cancer (CRC) screening ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators presented new data showing the critical role of blood-based testing ...
Regular preventive screenings can make a life-changing difference—especially when it comes to cancer. According to the ...
MedPage Today on MSN
Does stool-based test detect colorectal cancer as well in women?
Study finds FIT misses more cancers and precancerous lesions in women at standard threshol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results